546 related articles for article (PubMed ID: 24643989)
1. Relaxin augments BMP-2-induced osteoblast differentiation and bone formation.
Moon JS; Kim SH; Oh SH; Jeong YW; Kang JH; Park JC; Son HJ; Bae S; Park BI; Kim MS; Koh JT; Ko HM
J Bone Miner Res; 2014 Jul; 29(7):1586-96. PubMed ID: 24643989
[TBL] [Abstract][Full Text] [Related]
2. COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation.
Jeong BC; Kim HJ; Bae IH; Lee KN; Lee KY; Oh WM; Kim SH; Kang IC; Lee SE; Koh GY; Kim KK; Koh JT
Bone; 2010 Feb; 46(2):479-86. PubMed ID: 19782780
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
4. Astragaloside II induces osteogenic activities of osteoblasts through the bone morphogenetic protein-2/MAPK and Smad1/5/8 pathways.
Kong XH; Niu YB; Song XM; Zhao DD; Wang J; Wu XL; Zhang R; Mei QB
Int J Mol Med; 2012 Jun; 29(6):1090-8. PubMed ID: 22426655
[TBL] [Abstract][Full Text] [Related]
5. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells.
Kuo PL; Hsu YL; Chang CH; Chang JK
J Pharmacol Exp Ther; 2005 Sep; 314(3):1290-9. PubMed ID: 15956019
[TBL] [Abstract][Full Text] [Related]
6. Sphingosine 1-phosphate receptor activation enhances BMP-2-induced osteoblast differentiation.
Sato C; Iwasaki T; Kitano S; Tsunemi S; Sano H
Biochem Biophys Res Commun; 2012 Jun; 423(1):200-5. PubMed ID: 22659743
[TBL] [Abstract][Full Text] [Related]
7. Ugonin K promotes osteoblastic differentiation and mineralization by activation of p38 MAPK- and ERK-mediated expression of Runx2 and osterix.
Lee CH; Huang YL; Liao JF; Chiou WF
Eur J Pharmacol; 2011 Oct; 668(3):383-9. PubMed ID: 21806985
[TBL] [Abstract][Full Text] [Related]
8. Regulatory effects of fibroblast growth factor-8 and tumor necrosis factor-α on osteoblast marker expression induced by bone morphogenetic protein-2.
Katsuyama T; Otsuka F; Terasaka T; Inagaki K; Takano-Narazaki M; Matsumoto Y; Sada KE; Makino H
Peptides; 2015 Nov; 73():88-94. PubMed ID: 26409788
[TBL] [Abstract][Full Text] [Related]
9. Harmine promotes osteoblast differentiation through bone morphogenetic protein signaling.
Yonezawa T; Lee JW; Hibino A; Asai M; Hojo H; Cha BY; Teruya T; Nagai K; Chung UI; Yagasaki K; Woo JT
Biochem Biophys Res Commun; 2011 Jun; 409(2):260-5. PubMed ID: 21570953
[TBL] [Abstract][Full Text] [Related]
10. RELAXIN enhances differentiation and matrix mineralization through Relaxin/insulin-like family peptide receptor 2 (Rxfp2) in MC3T3-E1 cells in vitro.
Duarte C; Kobayashi Y; Kawamoto T; Moriyama K
Bone; 2014 Aug; 65():92-101. PubMed ID: 24857857
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures.
Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B
J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828
[TBL] [Abstract][Full Text] [Related]
12. Optimizing the osteogenic differentiation of human mesenchymal stromal cells by the synergistic action of growth factors.
Açil Y; Ghoniem AA; Wiltfang J; Gierloff M
J Craniomaxillofac Surg; 2014 Dec; 42(8):2002-9. PubMed ID: 25458345
[TBL] [Abstract][Full Text] [Related]
13. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype.
Phimphilai M; Zhao Z; Boules H; Roca H; Franceschi RT
J Bone Miner Res; 2006 Apr; 21(4):637-46. PubMed ID: 16598384
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α.
Takano M; Otsuka F; Matsumoto Y; Inagaki K; Takeda M; Nakamura E; Tsukamoto N; Miyoshi T; Sada KE; Makino H
Mol Cell Endocrinol; 2012 Jan; 348(1):224-32. PubMed ID: 21888945
[TBL] [Abstract][Full Text] [Related]
15. Collagen integrin receptors regulate early osteoblast differentiation induced by BMP-2.
Jikko A; Harris SE; Chen D; Mendrick DL; Damsky CH
J Bone Miner Res; 1999 Jul; 14(7):1075-83. PubMed ID: 10404007
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts.
Tang CH; Yang RS; Chien MY; Chen CC; Fu WM
Eur J Pharmacol; 2008 Jan; 579(1-3):40-9. PubMed ID: 17980360
[TBL] [Abstract][Full Text] [Related]
17. Linarin promotes osteogenic differentiation by activating the BMP-2/RUNX2 pathway via protein kinase A signaling.
Li J; Hao L; Wu J; Zhang J; Su J
Int J Mol Med; 2016 Apr; 37(4):901-10. PubMed ID: 26935542
[TBL] [Abstract][Full Text] [Related]
18. Combining bone morphogenetic proteins-2 and -6 has additive effects on osteoblastic differentiation in vitro and accelerates bone formation in vivo.
Visser R; Bodnarova K; Arrabal PM; Cifuentes M; Becerra J
J Biomed Mater Res A; 2016 Jan; 104(1):178-85. PubMed ID: 26238281
[TBL] [Abstract][Full Text] [Related]
19. M-Ras is activated by bone morphogenetic protein-2 and participates in osteoblastic determination, differentiation, and transdifferentiation.
Watanabe-Takano H; Takano K; Keduka E; Endo T
Exp Cell Res; 2010 Feb; 316(3):477-90. PubMed ID: 19800879
[TBL] [Abstract][Full Text] [Related]
20. Biphasic effects of transforming growth factor β on bone morphogenetic protein-induced osteoblast differentiation.
de Gorter DJ; van Dinther M; Korchynskyi O; ten Dijke P
J Bone Miner Res; 2011 Jun; 26(6):1178-87. PubMed ID: 21611961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]